Posted On: 11/18/2013 8:35:54 PM
Post# of 72446
Sorry Mac, you have had too much KoolAid. When will people realize, Leo writes the PR's and attributes statements to Dr Menon.... he did not actually say anything...
macnqueso Monday, 11/18/13 07:45:09 PM
Re: macnqueso post# 46307
Post # of 46317
Correction... in re-reading it looks like Menon (not Leo) was making the point...
Here is another point from the vetrinarian in today's PR...
"We knew we were gaining substantial assets with the PolyMedix acquisition, but this is evolving into more than even I expected at this point."
Today's PR is the direct result of re-organization activities which occurred since R&R... Kard staff being hired, Menon committing to a full-time effort... our Doc is in his wheel-house now... his greatest strength is his ability to identify marketable compounds in the pre-clinical phase... for those who know the work of Menon... this was a very fine PR...
Once you begin to view the PRs together... and not as stand alone documents... the snapshot really starts coming into focus... jmo...
macnqueso Monday, 11/18/13 07:45:09 PM
Re: macnqueso post# 46307
Post # of 46317
Correction... in re-reading it looks like Menon (not Leo) was making the point...
Here is another point from the vetrinarian in today's PR...
"We knew we were gaining substantial assets with the PolyMedix acquisition, but this is evolving into more than even I expected at this point."
Today's PR is the direct result of re-organization activities which occurred since R&R... Kard staff being hired, Menon committing to a full-time effort... our Doc is in his wheel-house now... his greatest strength is his ability to identify marketable compounds in the pre-clinical phase... for those who know the work of Menon... this was a very fine PR...
Once you begin to view the PRs together... and not as stand alone documents... the snapshot really starts coming into focus... jmo...
(0)
(0)
